Ranimycin, with the CAS number 11056-09-0, is an antibiotic compound that belongs to the class of rifamycins, which are known for their efficacy against a variety of bacterial infections. This substance exhibits a broad spectrum of antibacterial activity, particularly against Gram-positive bacteria and some Gram-negative strains. Ranimycin functions by inhibiting bacterial RNA synthesis, thereby interfering with the transcription process essential for bacterial growth and replication. It is often utilized in clinical settings for treating infections caused by susceptible organisms, including those resistant to other antibiotics. The compound is typically administered in specific dosages, and its pharmacokinetics can be influenced by factors such as the route of administration and the presence of food. As with many antibiotics, the potential for resistance development is a concern, necessitating careful use and adherence to prescribed regimens. Additionally, side effects may occur, and monitoring is essential to ensure patient safety and therapeutic efficacy.

Ranimycin

11056-09-0: Ranimycin, with the CAS number 11056-09-0, is an antibiotic compound that belongs to the class of rifamycins, which are known for their efficacy against a variety of bacterial infections. This substance exhibits a broad spectrum of antibacterial activity, particularly against Gram-positive bacteria and some Gram-negative strains. Ranimycin functions by inhibiting bacterial RNA synthesis, thereby interfering with the transcription process essential for bacterial growth and replication. It is often utilized in clinical settings for treating infections caused by susceptible organisms, including those resistant to other antibiotics. The compound is typically administered in specific dosages, and its pharmacokinetics can be influenced by factors such as the route of administration and the presence of food. As with many antibiotics, the potential for resistance development is a concern, necessitating careful use and adherence to prescribed regimens. Additionally, side effects may occur, and monitoring is essential to ensure patient safety and therapeutic efficacy.

<p>Ranimycin is an antibiotic, which is derived from a natural microbial source. It exhibits bactericidal activity by inhibiting bacterial protein synthesis, thereby preventing bacterial cell growth and proliferation. This disruption of protein synthesis is achieved through binding to the bacterial ribosome, effectively halting the process of translating mRNA into vital bacterial proteins, which are essential for their survival and replication.</p>

CAS 11056-09-0

Ranimycin

Ranimycin

Ref: 3D-AR163244